NYSE:VTR

Ventas Inc (VTR)

88.05
-0.32 (0.36%)
as of May 27, 2026, 8:00:00 pm Market Open.
8 watching
0
Investor Insights
star iconMay 28, 2026, 12:00 am

This summary was created by AI, based on 3 opinions in the last 12 months.

Ventas Inc. (VTR-N) stands out in the healthcare REIT sector, particularly in the realm of senior housing. The company's nursing homes are recognized as the top performers, boasting a price-to-FFO ratio of 20x and an impressive earnings growth rate of 10%. Additionally, Ventas has shown strong historical performance, notably in retirement homes, with a staggering increase of 2,177% in share value since 2000 and a remarkable average annual gain of nearly 20% over the last 25 years. The leadership is stable, as the CEO has been at the helm since 1999, contributing to the company's upward trajectory; this year alone, the stock is up 17%. Although it is currently viewed as slightly overbought, experts recommend a strategy of buying on dips and accumulating shares gradually, positioning Ventas as a growth-focused option in the healthcare REIT market, especially given the long-term trends in senior housing.

consensus icon
Consensus
Buy
valuation icon
Valuation
Fair Value
review icon
Similar
Welltower, WELL

Most recent Opinions go here

Be up to date, don't miss your chance.

BUY

Nursing homes. 20x FFO and 10% earnings growth.

BUY

Retirement homes have long been winners. Since 2000, shares are up 2,177%. Are #2 in this space. Boasts nearly 20% average annual gain for about 25 years. Has the lowest PE of this sector.

BUY ON WEAKNESS

Run by same CEO since 1999. Up 17% this year and is slightly overbought, so buy dips and accumulate slowly. A growth, not dividend, in healthcare REITs, particularly seniors housing, a growth area for years to come.

BUY ON WEAKNESS

Higher interest rates will weigh on this and other REITs. Their core business is seniors' homes, so long-term demographics are a tailwind. Their last quarter was in line, but shares were hammered. Pays a 4.3% dividend. Buy it gradually on the way down. You're paid to wait.

COMMENT
In assisted living, he would buy Ventas, but too many things can go wrong with this entire sector due to Omicron, so he wouldn't touch the sector right now.
BUY
A REIT that holds seniors' retirement homes, research centres, medical offices and hospitals. It got crushed last year, but has come back this year. Pays a 3.15% yield and he expects an increase.
PARTIAL BUY
It plunged $63 to $13 when Covid first hit in 2020, but it has rebounded recently to $57. It reported a slightly better than expected quarter but slightly worse guidance last Friday. However, the report boasted improving occupancy trends in the seniors housing division. This could be a bargain and the dividend could rise.
DON'T BUY
It is a healthcare REIT, so there is little reason for it to do well until the FED pauses. They have a short history.
DON'T BUY

One of the largest healthcare REITs. They are a very well managed company. He does not recommend it simply because it is real estate. When interest rates are rising it is bad for REITs.

TOP PICK

It is a REIT, the opposite of a bank. But it is in the health care medical niche. It recently spun off the nursing home business. It is an attractive entry point. She prefers exposure more to office than retail in REITs. She is out of retail, generally. (Analysts’ target: $64.00).

COMMENT

He likes the healthcare space, and this company owns medical office buildings, seniors’ homes, etc. This is generally a good business. However, being structured as a REIT, it has had a huge, huge run in share price and trades at a fairly steep valuation. It is vulnerable to interest rates coming down. He prefers Capital Senior Living (CSU-N) which trades at a much more modest valuation. Dividend yield of 4.2%.

WEAK BUY

A healthcare REIT. He owns a similar one. They are growth vehicles and trade significantly above NAV because they are constantly acquiring. The prices come off when there is a sign their acquisitions will drop off. They are looking at Canada. He thinks you are better buying companies they may want to acquire, however.

BUY

Seniors housing REIT in the US. He likes it. It has been clobbered. The decline is based on the broader US REIT index. People are getting older and you should see an increase in demand for seniors housing. You should see good rent increases. It is a little bit growth by acquisition based which is harder when you are trading at a discount.

COMMENT

American senior housing REIT. Nothing is broken with this company, but what they have done is announce a large transaction in Canada. If you are buying for the demographic story, you stick with it.

Showing 1 to 14 of 14 entries
  • «
  • 1
  • »

Ventas Inc (VTR) Frequently Asked Questions

What is Ventas Inc stock symbol?

Ventas Inc is a American stock, trading under the symbol VTR (previously VTR-N on Stockchase) on the New York Stock Exchange (VTR). It is usually referred to as NYSE:VTR or VTR

Is Ventas Inc a buy or a sell?

In the last year, 3 stock analysts published opinions about VTR (previously VTR-N on Stockchase). 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Ventas Inc.

Is Ventas Inc a good investment or a top pick?

Ventas Inc was recommended as a Top Pick by Derek Warren on 2014-06-13. Read the latest stock experts ratings for Ventas Inc.

Why is Ventas Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.

Is Ventas Inc worth watching?

3 stock analysts on Stockchase covered Ventas Inc in the last year. It is a trending stock that is worth watching.

What is Ventas Inc stock price?

On 2026-05-27, Ventas Inc (VTR) stock closed at a price of $88.05.